Community engagement to prevent Type II diabetes in urban Pakistan
Engagement of coMmunity Through Participatory Learning and Action for cOntrol and preVEntion of Type II Diabetes and Its Risk Factors [EMPOWER-D]: Feasibility Trial in Urban Pakistan
This study is trying a community-based program in urban Karachi to see if it can help prevent and manage Type II diabetes for people aged 20 and older.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 240 (estimated) |
| Ages | 20 Years and up |
| Sex | All |
| Sponsor | Baqai Institute of Diabetology and Endocrinology Academic / other |
| Locations | 1 site (Karachi, Sindh) |
| Trial ID | NCT06570057 on ClinicalTrials.gov |
What this trial studies
This project focuses on adapting, implementing, and evaluating a Participatory Learning and Action (PLA) based intervention aimed at preventing and controlling Type II diabetes in urban Karachi, Pakistan. The intervention is designed to enhance community participation and address the social and behavioral determinants of health. By utilizing evidence-based approaches and best practices, the trial seeks to assess the feasibility and effectiveness of this intervention in an urban context, which has not been previously tested. The study will involve individuals aged 20 and above, including those with normoglycemia, intermediate hyperglycemia, and diabetes, to foster a comprehensive community approach to diabetes management.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals aged 20 years and above residing in Karachi, Pakistan, who are willing to participate and provide consent.
Not a fit: Patients under the age of 20 or those with severe health conditions that may hinder their participation will not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly reduce the incidence and impact of Type II diabetes in urban populations, improving overall community health.
How similar studies have performed: Similar approaches have shown success in rural settings, but this specific PLA-based intervention has not been tested in urban communities, making it a novel endeavor.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Individuals aged 20 years and above. * Participants residing in the randomized clusters of Karachi, Pakistan * Individuals willing to participate in the study and provide consent. * Both individuals with normoglycemia, intermediate hyperglycemia, and diabetes are encouraged to participate. * Participants who can attend the scheduled meetings and interventions as per the study protocol. Exclusion Criteria: * Individuals below the age of 20 years. * Individuals unwilling to provide consent for participation. * Participants with severe health conditions that may hinder their active involvement in the study. * Individuals with non-compliance with research protocols
Where this trial is running
Karachi, Sindh
- Baqai Institute of Diabetology and Endocrinology (BIDE) — Karachi, Sindh, Pakistan (Recruiting)
Study contacts
- Principal investigator: Abdul Basit, Director — Baqai Institute of Diabetes and Endocrinology
- Study coordinator: Abdul Basit, Director
- Email: abdulbasit@bide.edu.pk
- Phone: 922136688897
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.